Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
[Some advice on prevention strategy of atherosclerosis].

Zhonghua nei ke za zhi

Hu DY, Shi XB.
PMID: 24439181
Zhonghua Nei Ke Za Zhi. 2013 Nov;52(11):915-7.

No abstract available.

Cite
Hu DY, Shi XB. [Some advice on prevention strategy of atherosclerosis]. Zhonghua Nei Ke Za Zhi. 2013;52(11):915-7
Hu, D. Y., & Shi, X. B. (2013). [Some advice on prevention strategy of atherosclerosis]. Zhonghua nei ke za zhi, 52(11), 915-7.
Hu, Da-yi, and Shi, Xu-bo. "[Some advice on prevention strategy of atherosclerosis]." Zhonghua nei ke za zhi vol. 52,11 (2013): 915-7.
Hu DY, Shi XB. [Some advice on prevention strategy of atherosclerosis]. Zhonghua Nei Ke Za Zhi. 2013 Nov;52(11):915-7. Chinese. PMID: 24439181.
Copy Download .nbib Format: NLM
[Prevention of atherosclerosis in children -Increased subclinical atherosclerosis in children with metabolic syndrome-].

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics

Hara M.
PMID: 20616441
Nihon Ronen Igakkai Zasshi. 2010;47(3):191-3. doi: 10.3143/geriatrics.47.191.

No abstract available.

Cite
Hara M. [Prevention of atherosclerosis in children -Increased subclinical atherosclerosis in children with metabolic syndrome-]. Nihon Ronen Igakkai Zasshi. 2010;47(3):191-3doi: 10.3143/geriatrics.47.191.
Hara, M. (2010). [Prevention of atherosclerosis in children -Increased subclinical atherosclerosis in children with metabolic syndrome-]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 47(3), 191-3. https://doi.org/10.3143/geriatrics.47.191
Hara, Mitsuhiko. "[Prevention of atherosclerosis in children -Increased subclinical atherosclerosis in children with metabolic syndrome-]." Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics vol. 47,3 (2010): 191-3. doi: https://doi.org/10.3143/geriatrics.47.191
Hara M. [Prevention of atherosclerosis in children -Increased subclinical atherosclerosis in children with metabolic syndrome-]. Nihon Ronen Igakkai Zasshi. 2010;47(3):191-3. doi: 10.3143/geriatrics.47.191. Japanese. PMID: 20616441.
Copy Download .nbib Format: NLM
[Consultation for the prevention of atherosclerotic diseases].

Rinsho byori. The Japanese journal of clinical pathology

Okada M, Matsuto T, Miida T, Takahashi A.
PMID: 16190356
Rinsho Byori. 2005 Aug;53(8):708-11.

We have conducted a population-based, long-term trial with the purpose of investigating risk factors for atherosclerotic diseases in a Japanese population, from 1996 (Niigata Study). Through the trial, we have learned what is going on at the initial phase...

Cite
Okada M, Matsuto T, Miida T, et al. [Consultation for the prevention of atherosclerotic diseases]. Rinsho Byori. 2005;53(8):708-11
Okada, M., Matsuto, T., Miida, T., & Takahashi, A. (2005). [Consultation for the prevention of atherosclerotic diseases]. Rinsho byori. The Japanese journal of clinical pathology, 53(8), 708-11.
Okada, Masahiko, et al. "[Consultation for the prevention of atherosclerotic diseases]." Rinsho byori. The Japanese journal of clinical pathology vol. 53,8 (2005): 708-11.
Okada M, Matsuto T, Miida T, Takahashi A. [Consultation for the prevention of atherosclerotic diseases]. Rinsho Byori. 2005 Aug;53(8):708-11. Japanese. PMID: 16190356.
Copy Download .nbib Format: NLM
Preserve vascular health to lower risk of dementia. Treating atherosclerosis may help preserve cognitive function later in life.

DukeMedicine healthnews

[No authors listed]
PMID: 22039621
Duke Med Health News. 2011 Oct;17(10):1-2.

No abstract available.

Cite
Preserve vascular health to lower risk of dementia. Treating atherosclerosis may help preserve cognitive function later in life. Duke Med Health News. 2011;17(10):1-2
(2011). Preserve vascular health to lower risk of dementia. Treating atherosclerosis may help preserve cognitive function later in life. DukeMedicine healthnews, 17(10), 1-2.
"Preserve vascular health to lower risk of dementia. Treating atherosclerosis may help preserve cognitive function later in life." DukeMedicine healthnews vol. 17,10 (2011): 1-2.
Preserve vascular health to lower risk of dementia. Treating atherosclerosis may help preserve cognitive function later in life. Duke Med Health News. 2011 Oct;17(10):1-2. PMID: 22039621.
Copy Download .nbib Format: NLM
Emerging risk factors for atherosclerosis.

Indian heart journal

John JM, Bhatt DL.
PMID: 19098332
Indian Heart J. 2007 Jan-Feb;59(1):28-37.

No abstract available.

Cite
John JM, Bhatt DL. Emerging risk factors for atherosclerosis. Indian Heart J. 2007;59(1):28-37
John, J. M., & Bhatt, D. L. (2007). Emerging risk factors for atherosclerosis. Indian heart journal, 59(1), 28-37.
John, Jim M, and Bhatt, Deepak L. "Emerging risk factors for atherosclerosis." Indian heart journal vol. 59,1 (2007): 28-37.
John JM, Bhatt DL. Emerging risk factors for atherosclerosis. Indian Heart J. 2007 Jan-Feb;59(1):28-37. PMID: 19098332.
Copy Download .nbib Format: NLM
Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice.

Current opinion in lipidology

Watts GF, Stroes ESG.
PMID: 31688168
Curr Opin Lipidol. 2019 Dec;30(6):417-418. doi: 10.1097/MOL.0000000000000650.

No abstract available.

Cite
Watts GF, Stroes ESG. Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice. Curr Opin Lipidol. 2019;30(6):417-418doi: 10.1097/MOL.0000000000000650.
Watts, G. F., & Stroes, E. S. G. (2019). Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice. Current opinion in lipidology, 30(6), 417-418. https://doi.org/10.1097/MOL.0000000000000650
Watts, Gerald F, and Stroes, Eric S G. "Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice." Current opinion in lipidology vol. 30,6 (2019): 417-418. doi: https://doi.org/10.1097/MOL.0000000000000650
Watts GF, Stroes ESG. Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice. Curr Opin Lipidol. 2019 Dec;30(6):417-418. doi: 10.1097/MOL.0000000000000650. PMID: 31688168.
Copy Download .nbib Format: NLM
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.

European journal of preventive cardiology

Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J.
PMID: 31408370
Eur J Prev Cardiol. 2020 Mar;27(4):394-406. doi: 10.1177/2047487319869400. Epub 2019 Aug 13.

Despite major efforts to reduce atherosclerotic cardiovascular disease (ASCVD) burden with conventional risk factor control, significant residual risk remains. Recent evidence on non-traditional determinants of cardiometabolic health has advanced our understanding of lifestyle-disease interactions. Chronic exposure to environmental stressors...

Cite
Lechner K, von Schacky C, McKenzie AL, et al. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2019;27(4):394-406doi: 10.1177/2047487319869400.
Lechner, K., von Schacky, C., McKenzie, A. L., Worm, N., Nixdorff, U., Lechner, B., Kränkel, N., Halle, M., Krauss, R. M., & Scherr, J. (2020). Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. European journal of preventive cardiology, 27(4), 394-406. https://doi.org/10.1177/2047487319869400
Lechner, Katharina, et al. "Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors." European journal of preventive cardiology vol. 27,4 (2020): 394-406. doi: https://doi.org/10.1177/2047487319869400
Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2020 Mar;27(4):394-406. doi: 10.1177/2047487319869400. Epub 2019 Aug 13. PMID: 31408370; PMCID: PMC7065445.
Copy Download .nbib Format: NLM
Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions.

Methodist DeBakey cardiovascular journal

Wong WT, Ma S, Tian XY, Gonzalez AB, Ebong EE, Shen H.
PMID: 27826369
Methodist Debakey Cardiovasc J. 2016 Sep;12(3):152-156. doi: 10.14797/mdcj-12-3-152.

Atherosclerosis is a chronic inflammatory vascular wall disease, and endothelial cell dysfunction plays an important role in its development and progression. Under the influence of laminar shear stress, however, the endothelium releases homeostatic factors such as nitric oxide and...

Cite
Wong WT, Ma S, Tian XY, et al. Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions. Methodist Debakey Cardiovasc J. 2016;12(3):152-156doi: 10.14797/mdcj-12-3-152.
Wong, W. T., Ma, S., Tian, X. Y., Gonzalez, A. B., Ebong, E. E., & Shen, H. (2016). Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions. Methodist DeBakey cardiovascular journal, 12(3), 152-156. https://doi.org/10.14797/mdcj-12-3-152
Wong, Wing Tak, et al. "Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions." Methodist DeBakey cardiovascular journal vol. 12,3 (2016): 152-156. doi: https://doi.org/10.14797/mdcj-12-3-152
Wong WT, Ma S, Tian XY, Gonzalez AB, Ebong EE, Shen H. Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions. Methodist Debakey Cardiovasc J. 2016 Sep;12(3):152-156. doi: 10.14797/mdcj-12-3-152. PMID: 27826369; PMCID: PMC5098572.
Copy Download .nbib Format: NLM
Fortified Tregs to fight atherosclerosis.

Cardiovascular research

Ley K.
PMID: 33744912
Cardiovasc Res. 2021 Jul 27;117(9):1987-1988. doi: 10.1093/cvr/cvab103.

No abstract available.

Cite
Ley K. Fortified Tregs to fight atherosclerosis. Cardiovasc Res. 2021;117(9):1987-1988doi: 10.1093/cvr/cvab103.
Ley, K. (2021). Fortified Tregs to fight atherosclerosis. Cardiovascular research, 117(9), 1987-1988. https://doi.org/10.1093/cvr/cvab103
Ley, Klaus. "Fortified Tregs to fight atherosclerosis." Cardiovascular research vol. 117,9 (2021): 1987-1988. doi: https://doi.org/10.1093/cvr/cvab103
Ley K. Fortified Tregs to fight atherosclerosis. Cardiovasc Res. 2021 Jul 27;117(9):1987-1988. doi: 10.1093/cvr/cvab103. PMID: 33744912; PMCID: PMC8318100.
Copy Download .nbib Format: NLM
Whole-body MRI as a screening tool?.

European journal of radiology

Ladd SC.
PMID: 19345540
Eur J Radiol. 2009 Jun;70(3):452-62. doi: 10.1016/j.ejrad.2009.02.011. Epub 2009 Apr 03.

Screening (early detection of disease in asymptomatic groups of persons) with whole-body MR (wb-MR) has only recently become possible. Technical requirements include extended scanner table range and extended coverage with surface coils. This allows for examining the whole body...

Cite
Ladd SC. Whole-body MRI as a screening tool?. Eur J Radiol. 2009;70(3):452-62doi: 10.1016/j.ejrad.2009.02.011.
Ladd, S. C. (2009). Whole-body MRI as a screening tool?. European journal of radiology, 70(3), 452-62. https://doi.org/10.1016/j.ejrad.2009.02.011
Ladd, Susanne C. "Whole-body MRI as a screening tool?." European journal of radiology vol. 70,3 (2009): 452-62. doi: https://doi.org/10.1016/j.ejrad.2009.02.011
Ladd SC. Whole-body MRI as a screening tool?. Eur J Radiol. 2009 Jun;70(3):452-62. doi: 10.1016/j.ejrad.2009.02.011. Epub 2009 Apr 03. PMID: 19345540.
Copy Download .nbib Format: NLM
Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review.

Diabetes & metabolic syndrome

Singh TP, Vangaveti VN, Malabu UH.
PMID: 26067782
Diabetes Metab Syndr. 2015 Oct-Dec;9(4):223-9. doi: 10.1016/j.dsx.2015.04.005. Epub 2015 Jun 02.

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of anti-diabetic drugs that have therapeutic potential in the management of atherosclerosis. Of the numerous DPP-4 inhibitors in clinical practice no studies have been conducted to compare their anti-atherosclerotic...

Cite
Singh TP, Vangaveti VN, Malabu UH. Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review. Diabetes Metab Syndr. 2015;9(4):223-9doi: 10.1016/j.dsx.2015.04.005.
Singh, T. P., Vangaveti, V. N., & Malabu, U. H. (2015). Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review. Diabetes & metabolic syndrome, 9(4), 223-9. https://doi.org/10.1016/j.dsx.2015.04.005
Singh, Tejas P, et al. "Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review." Diabetes & metabolic syndrome vol. 9,4 (2015): 223-9. doi: https://doi.org/10.1016/j.dsx.2015.04.005
Singh TP, Vangaveti VN, Malabu UH. Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review. Diabetes Metab Syndr. 2015 Oct-Dec;9(4):223-9. doi: 10.1016/j.dsx.2015.04.005. Epub 2015 Jun 02. PMID: 26067782.
Copy Download .nbib Format: NLM
[Programs for Continuing Medical Education 2016: A Session: 5. Management of Life Style-related Disease to Prevent Atherosclerosis].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Yokote K.
PMID: 30182688
Nihon Naika Gakkai Zasshi. 2017 Mar;106(3):484-9.

No abstract available.

Cite
Yokote K. [Programs for Continuing Medical Education 2016: A Session: 5. Management of Life Style-related Disease to Prevent Atherosclerosis]. Nihon Naika Gakkai Zasshi. 2017;106(3):484-9
Yokote, K. (2017). [Programs for Continuing Medical Education 2016: A Session: 5. Management of Life Style-related Disease to Prevent Atherosclerosis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 106(3), 484-9.
Yokote, Koutaro. "[Programs for Continuing Medical Education 2016: A Session: 5. Management of Life Style-related Disease to Prevent Atherosclerosis]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 106,3 (2017): 484-9.
Yokote K. [Programs for Continuing Medical Education 2016: A Session: 5. Management of Life Style-related Disease to Prevent Atherosclerosis]. Nihon Naika Gakkai Zasshi. 2017 Mar;106(3):484-9. Japanese. PMID: 30182688.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries